Slavica Krantic, PhD

Primary tabs

JAD profile

Site Participation

Cognitive reserve in ageing and Alzheimer's disease.
March 4, 2016
The review provides a comprehensive overview of the "state of the art" about the cognitive reserve. Most importantly, it...
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
March 4, 2016
Very useful for the clarification of terms and concepts used in the study of preclinical stage of AD.
Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.
March 4, 2016
This work presents the data indicating that optimal (neither too low, nor excess) hippocampal activation is required for normal...
Caspase signalling controls microglia activation and neurotoxicity.
March 4, 2016
This paper is important since it brings evidence suggesting that caspase activation previously detected in biochemical studies...
Plasma phospholipids identify antecedent memory impairment in older adults.
March 4, 2016
The authors propose and validate the plasma phospholipid content as an attractive option for preclinical AD diagnostic marker....
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.
March 4, 2016
The fact that aggregated amyloid-beta is not a potent activator of mouse complement system is often forgotten when studying AD-...
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
March 4, 2016
The authors present the evidence that tauopathy may begin in sporadic AD much earlier than initially thought. They suggest that...
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
March 4, 2016
This paper reports on the identification of A673T  mutation in the APP gene yielding protection against Alzheimer's disease and...